Stenabolic (SR9009) 25mg Capsules – REV-ERB Research Compound

SR9009 Stenabolic Capsules for Laboratory Research

Stenabolic (SR9009) is an investigational research compound supplied in capsules containing 25mg of SR9009 per capsule. Unlike selective androgen receptor modulators (SARMs), Stenabolic is a synthetic REV-ERB agonist that has been investigated in preclinical research involving circadian biology, metabolic signalling, mitochondrial processes, and cellular energy regulation.

Also commonly known as SR9009, the compound provides applications within experimental models investigating REV-ERB activity, metabolic pathways, circadian regulation, and associated cellular mechanisms.

Why Choose Stenabolic (SR9009)?

SR9009 has attracted research interest due to its interaction with REV-ERB nuclear receptors, which are involved in the regulation of biological processes associated with metabolism and circadian rhythms.

Preclinical research involving Stenabolic has examined areas including energy metabolism, mitochondrial function, lipid and glucose pathways, circadian signalling, and REV-ERB-mediated biological activity.

Its distinctive mechanism makes SR9009 relevant to comparative laboratory models involving metabolic research compounds, nuclear receptor signalling, and circadian biology.

Key Features

REV-ERB Agonist Research Compound

Stenabolic (SR9009) is referenced in preclinical research examining REV-ERB receptor activity and associated biological signalling pathways.

25mg Per Capsule

Each capsule contains 25mg of Stenabolic (SR9009), providing a clearly defined quantity for structured laboratory research protocols.

Metabolic Pathway Research

SR9009 has been investigated in experimental models examining energy metabolism, lipid pathways, glucose regulation, and associated metabolic mechanisms.

Circadian Rhythm Research

REV-ERB receptors have an important role within the biological circadian system, making SR9009 relevant to research examining circadian signalling and biological rhythm regulation.

Mitochondrial & Cellular Research

Stenabolic provides applications within preclinical models investigating mitochondrial processes, cellular energy regulation, and associated metabolic activity.

Product Details

• Active Compound: Stenabolic (SR9009)
• Compound Code: SR9009
• Common Name: Stenabolic
• Dosage: 25mg per capsule
• Format: Capsule-based research compound
• Compound Type: REV-ERB Agonist
• Category: Metabolic / Research Compound

Ingredients

• Stenabolic (SR9009) – 25mg
• Vegetarian Capsule Shell: Cellulose and purified water
• No additional active ingredients